SpyreTherapeutics News & Analysis

Spyre Therapeutics' Chief Legal Officer Sells $2.63 Million

Spyre Therapeutics' chief legal officer has sold $2.63 million worth of the company's shares. This sale was conducted by the legal department head of Spyre Therapeutics, though further specifics about timing or reasons for the sale were not disclosed in the article. Spyre Therapeutics has not provided additional comments regarding the transaction. Such insider sales might affect investor confidence depending on the perceived reasons behind the sell-off.